Navigation Links
Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
Date:10/29/2008

Predictive model shows shots would also save $7 billion in related health-care costs

WEDNESDAY, Oct. 29 (HealthDay News) -- Vaccinating infants with what's known as the "7 valent pneumococcal conjugate vaccine" (PCV7) could save more than 357,000 lives and $7 billion in costs by preventing bacterial infections during a flu pandemic, according to a predictive model developed by U.S. researchers.

Pneumococcal disease (such as meningitis) and other bacterial infections can follow flu and cause secondary infections that worsen flu symptoms and increase the risk of flu-related death. For example, it's believed that bacterial infections caused almost half of the deaths of young soldiers during the 1918 worldwide flu pandemic, according to background information in an Emory University news release.

"We've known for years that bacterial infections can develop after influenza. Unlike the 1918 flu pandemic, which preceded the antibiotic era, we now have vaccines that can prevent these types of pneumococcal infections. This model shows what a dramatically different outcome we could expect with standard PCV vaccination," Keith P. Klugman, professor of global health at Emory's Rollins School of Public Health, said in the news release.

He and colleagues at Harvard University, i3 Innovus in Medford. Mass., and Wyeth Research created a model to estimate the public health and economic effect current influenza vaccination practices would have on children younger than two years old during a flu pandemic. Since 2000, the Centers for Disease Control and Prevention has recommended PCV vaccinations for infants and children.

The model showed that current PCV vaccination practices lower costs in a typical flu season by $1.4 billion and would cut costs by $7 billion in a pandemic. It also predicted that PCV vaccination would prevent 1.24 million cases of pneumonia and 357,000 pneumococcal-related deaths in a pandemic.

The findings were presented this week at an infectious diseases conference in Washington, D.C.

"Our research shows that routine pneumococcal vaccination is a proactive approach that can greatly reduce the effects of a future flu pandemic," Klugman said. "Countries that have not yet implemented a pneumococcal vaccination program may want to consider this as part of their pandemic flu preparedness."

Klugman is a paid consultant for Wyeth Pharmaceuticals, which funded the study.

More information

The Immunization Action Coalition has more about pneumococcal diseases.



-- Robert Preidt



SOURCE: Emory University, news release, Oct. 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: